CRISPR Drug Development
University of Texas Southwest, Eric Olson, PhD
ACTION
Advanced Cardiac Therapies Improving Outcomes Network
Duchenne Program
UMass Medical School, Dr. Brenda Wong
Expansion of Department of Defense Grant – Cardiac
Northwestern University, Dr. Elizabeth McNally
Hope for Gus founder Tonya Dreher receives the 2022 Greg Farrell Award
We are delighted to announce that Tonya Dreher has been named as the recipient of the 2022 Greg Farrell Award.
Hope for Gus Mount Everest Hike Helps Raise Awareness for DMD
Jill said she’s honored to have participated in the trek. “I’m grateful to get the word out about Duchenne and to share this experience with others who we
A Trek to Everest to Raise Funds
That is the point of the Everest to End Duchenne fundraiser, said Tonya Dreher, Gus’ mother and director of Hope for Gus. The hike serves as a reminder of the difficulties faced by someone with Duchenne on a daily basis.
The Duchenne Alliance commits $500,000 to fund first Duchenne Follistatin Gene Therapy Trial
The International Duchenne Alliance announced today that it will allocate $500,000 to Jerry Mendell, M.D. and Milo Biotechnology to support the first ever follistatin gene therapy trial for DMD.
Hope for Gus collaborates with other foundations to fund Phrixus Phameceuticals
Phrixus Pharmaceuticals, Inc. today announced that it has received $67,374 in sponsored research funding from a number of DMD parent organization through the DuchenneDashboard.
Hope for Gus collaborates with other foundations to fund development of Halfuginone
Halo Therapeutics, LLC, a clinical-stage biopharmaceutical company developing novel therapeutics for rare fibrotic diseases, announced today that it has received financial support totaling $1.1 million from 12 not-for-profit foundations, including Hope For Gus.